Induction of matrix metalloproteinases and a collagen-degrading phenotype in fibroblasts and epithelial cells by secreted Porphyromonas gingivalis proteinase

Journal of Periodontal Research

Volumn 33, Issue 7, 1998, Pages 408-420

  DeCarlo, Arthur A ^a,f   Grenett, Hernan E ^b   Harber, Greg J ^c   Windsor, L Jack ^c   Bodden, M Kirby ^b   Birkedal Hansen, Bente ^d   Birkedal Hansen, Henning ^e  

^a University of Alabama at Birmingham   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^d NATIONAL CANCER INSTITUTE   (United States)

^e NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

^f Sydney Local Health District   (Australia)

Author keywords

Gingipain; MMPs; Periodontits, P. gingivalis; Wound healing

Indexed keywords

ADHESIN; BACTERIAL PROTEIN; COLLAGEN; CYSTEINE PROTEINASE; HEMAGGLUTININ; LYS GINGIPAIN; LYS-GINGIPAIN; MESSENGER RNA; METALLOPROTEINASE;

ANIMAL; ARTICLE; BIOSYNTHESIS; CELL CULTURE; CULTURE MEDIUM; CYTOLOGY; ENZYMOLOGY; EPITHELIUM CELL; EXTRACELLULAR MATRIX; FIBROBLAST; HUMAN; METABOLISM; MICROBIOLOGY; MOLECULAR GENETICS; MOUTH MUCOSA; NUCLEOTIDE SEQUENCE; PATHOGENICITY; PERIODONTAL LIGAMENT; PERIODONTITIS; PORPHYROMONAS GINGIVALIS; RAT; UPREGULATION;

ADHESINS, BACTERIAL; ANIMALS; BACTERIAL PROTEINS; BASE SEQUENCE; CELLS, CULTURED; COLLAGEN; CULTURE MEDIA, CONDITIONED; CYSTEINE ENDOPEPTIDASES; EPITHELIAL CELLS; EXTRACELLULAR MATRIX; FIBROBLASTS; HEMAGGLUTININS; HUMANS; METALLOENDOPEPTIDASES; MOLECULAR SEQUENCE DATA; MOUTH MUCOSA; PERIODONTAL LIGAMENT; PERIODONTITIS; PORPHYROMONAS GINGIVALIS; RATS; RNA, MESSENGER; UP-REGULATION;

EID: 0032176423     PISSN: 00223484     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0765.1998.tb02337.x     Document Type: Article

References (86)

1. Golub LM, Lee HM, Greenwald RA, et al. A matrix metalloproteinase inhibitor reduces bone-type collagen degradation fragments and specific collagenases in gingival crevicular fluid during adult periodontitis. Inflam Res 1997; 46: 310-319.
2. Lamster IB, Smith QT, Celenti RS, Singer RE, Grbic JT. Development of a risk profile for periodontal disease: microbial and host response factors. J Periodontol 1994; 65: 511-520.
3. Daniel MA, Van Dyke TE. Alterations in phagocyte function and periodontal infection. J Periodontol 1996; 67: 1070-1075.
4. Eley BM, Cox SW. Correlation between gingivain/gingipain and bacterial dipeptidyl peptidase activity in gingival crevicular fluid and periodontal attachment loss in chronic periodontitis patients. A 2-year longitudinal study. J Periodontol 1996; 67: 703-716.
5. Birkedal-Hansen H. Role of matrix metalloproteinases in human periodontal diseases. J Periodontol 1993; 64: 474-484.
6. Offenbacher S, Collins JG, Yalda B, Haradon G. Role of prostaglandins in high-risk periodontitis patients. In: Genco R, Hamada S, Lehner T, McGee J Mergenhagen S, eds. Molecular pathogenesis of periodontal disease. Washington, DC: American Society for Microbiology Press, 1994; 203-213.
7. Sodek J, Overall CM. Matrix metalloproteinases in periodontal tissue remodelling. In: Birkedal-Hansen H, Werb Z, Welgus HG, Van Wart HE, eds. Matrix metalloproteinases and inhibitors. Stuttgart: Gustav Fischer, 1992; 352-362.
8. Taubman MA, Eastcott JW. Shimauchi H, Takeichi O, Smith DJ. Modulatory role of T lymphocytes in periodontal inflammation. In: Genco R, Hamada S, Lehner T, McGee J Mergenhagen S, eds. Molecular pathogenesis of periodontal disease. Washington, DC: American Society for Microbiology Press, 1994; 147-157.
9. Albandar JM, Brown LJ, Löe H. Putative periodontal pathogens in subgingival plaque of young adults with and without early-onset periodontitis. J Periodontol 1997; 68: 973-981.
10. Dzink JL, Socransky SS, Haffajee AD. The predominant cultivable microbiota of active and inactive lesions of destructive periodontal diseases. J Clin Periodontol 1988; 15: 316-323.
11. Moore WEC. Microbiology of periodontal disease. J Periodont Res 1987; 22: 335-341.
12. Slots J, Genco RJ. Microbial pathogenicity. J Dent Res 1984; 63: 412-421.
13. Socransky SS, Haffajee AD, Dzink JL. Relationship of subgingival microbial complexes to clinical features at the sampled sites. J Clin Periodontol 1988: 15: 440-444.
14. Saarialho-Kere UK, Kovacs SO, Pentland AP, Olerud JE, Welgus HG, Parks WC. Cell-matrix interactions modulate interstitial collagenase expression by human keratinocytes actively involved in wound healing. J Clin Invest 1994; 92: 2858-2866.
15. Stricklin GP, Li L, Nanney LB. Localization of mRNAs representing interstitial collagenase, 72-kDa gelatinase, and TIMP in healing porcine burn wounds. J Invest Derm 1994; 103: 352-358.
16. Häyrinen-Immonen R, Sorsa T, Nordström D, Malmström M, Konttinen YT. Collagenase and stromelysin in recurrent apthous ulcers (RAU). Int J Oral Maxillo Surg 1993; 22: 46-49.
17. Saarialho-Kere UK, Vaalamo M, Airola K, Niemi K-M, Oikarinen AI, Parks WC. Interstitial collagenase is expressed by keratinocytes that are actively involved in reepithelialization in blistering skin diseases. J Invest Derm 1995; 104: 982-988.
18. Madlener M, Mauch C, Conca W, Brauchle M, Parks WC, Werner S. Regulation of the expression of stromelysin-2 by growth factors in keratinocytes: implications for normal and impaired wound healing. Biochem J 1996; 320: 659-664.
19. Garlick JA, Parks WC, Welgus HG, Taichman LB. Re-epithelialization of human oral keratinocytes in vitro. J Dent Res 1996; 75: 912-918.
20. Stotts NA, Hunt TK. Managing bacterial colonization and infection. Clin Ger Med 1997; 13: 565-573.
21. Yager DR, Zhang L-Y, Diegelmann RF, Cohen IK. Wound fluids from human pressure ulcers contain elevated matrix metalloproteinase levels and activity compared to surgical wound fluids. J Invest Derm 1996; 107: 743-748.
22. Borden P, Heller RA. Transcriptional control of matrix metalloproteinases and the tissue inhibitors of matrix metalloproteinases. Crit Rev Euk Gene Expr 1997; 7: 159-178.
23. Birkedal-Hansen H, Moore WGI, Bodden MK, et al. Matrix metalloproteinases: a review. Crit Rev Oral Biol Med 1993; 4: 197-250.
24. Eriksen EF. Normal and pathological remodeling of human trabecular bone: three dimensional reconstruction of the remodeling sequence in normals and in metabolic bone disease. Endoc Rev 1986; 7: 379-408.
25. Kokorine I, Marbaix E, Henriet P, et al Focal cellular origin and regulation of interstitial collagenase (matrix metalloproteinase-1) are related to menstrual breakdown in the human endometrium. J Cell Sci 1996; 109: 2151-2160.
26. Vaes G, Delaisse J-M, Eeckhout Y. Relative roles of collagenase and lysosomal cysteine-proteinases in bone resorption. In: Birkedal-Hansen H, Werb Z, Welgus HG, Van Wart HE, eds. Matrix metalloproteinases and inhibitors. Stuttgart: Gustav Fischer, 1992; 383-388.
27. Fisher C, Gilbertson-Beadling S, Powers EA, Petzold G, Poorman R, Mitchell MA. Interstitial collagenase is required for angiogenesis in vitro. Dev Biol 1994; 162: 499-510.
28. Werb Z, Alexander CM, Adler RR. Expression and function of matrix metalloproteinases in development. In: Birkedal-Hansen H, Werb Z, Welgus HG, Van Wart HE, eds. Matrix metalloproteinases and inhibitors. Stuttgart: Gustav Fischer, 1992; 337-343.
29. Meikle MC, Hembry RM, Holley J, Horton C, McFarlane CG, Reynolds JJ. Immunolocalization of matrix metalloproteinases and TIMP-1 (tissue inhibitor of metalloproteinases) in human gingival tissues from periodontitis patients. J Periodont Res 1994; 29: 118-126.
30. Lindy O, Konttinen YT, Sorsa T, et al. Matrix metalloproteinase 13 (collagenase 3) in human rheumatoid synovium. Arth Rheum 1997; 40: 1391-1399.
31. Johansson N, Airola K, Grénman R, Kariniemi A-L, Saarialho-Kere U, Kähäri V-M. Expression of collagenase-3 (matrix metalloprotcinase-13) in squamous cell carcinomas of the head and neck. Am J Pathol 1997; 151: 499-508.
32. Robert V, Besse S, Sabri A, et al. Differential regulation of matrix metalloproteinases associated with aging and hypertension in the rat heart. Lab Invest 1997; 76: 729-738.
33. Chandler S, Miller KM, Clements JM, et al. Matrix metalloproteinases, tumor necrosis factor and mutiple sclerosis: an overview. J Neuroimmunol 1997; 72: 155-161.
34. Brinckerhoff CE. Regulation of metalloproteinase gene expression: implication for ostcoarthritis. Crit Rev Euk Gene Expr 1992; 2: 145-164.
35. Firestein GS. Mechanisms of tissue destruction and cellular activation in rheumatoid arthritis. Curr Opin Rheumatol 1992; 4: 348-354.
36. Goldberg GI, Eisen AZ. Extracellular matrix metalloproteinases in tumor invasion and metastasis. Cancer Treat Res 1991; 53: 421-440.
37. Matrisian LM, McDonnell S, Miller DB, Navre M, Seftor EA, Hendrix MJ. The role of the matrix metalloproteinase stromelysin in the progression of squamous cell carcinomas. Am J Med Sci 1991; 302: 157-162.
38. Mignatti P, Rifkin DB. Biology and biochemistry of proteinases in tumor invasion. Physiol Rev 1993; 73: 161-195.
39. Tryggvason K, Hoyhtya M, Pyke C. Type IV collagenases in invasive tumors. Breast Cancer Res Treat 1993; 24: 209-218.
40. Heppner KJ, Matrisian LM, Jensen RA, Rodgers WH. Expression of most matrix metalloproteinase family members in breast cancer represents a tumor-induced host response. Am J Pathol 1996; 149: 273-282.
41. Vaalamo M, Mattila L, Johansson N, et al. Distinct populations of stromal cells express collagenase-3 (MMP-13) and collagenase-1 (MMP-1) in chronic ulcers but not in normally healing wounds. J Invest Derm 1997; 109: 96-101.
42. Mitchell PG, Magna HA, Reeves LM, et al. Cloning, expression, and type II collagenolytic activity of matrix metalloproteinase-13 from human osteoarthritic cartilage. J Clin Invest 1996; 97: 761-768.
43. Freije JMP, Diez-Itza I, Balbin M, et al. Molecular cloning and expression of collagenase-3, a novel human matrix metalloproteinase produced by breast carcinomas. J Biol Chem 1994; 269: 16766-16773.
44. Ståhle-Backdahl M, Sandstedt B, Bruce K, et al Collagenase-3 (MMP-13) is expressed during human fetal ossification and re-expressed in postnatal bone remodeling and in rheumatoid arthritis. Lab Invest 1997; 76: 717-728.
45. Henriet P, Rowsseau GG, Eeckhaout Y. Cloning and sequencing of mouse collagenase cDNA. Divergence of mouse and rat collagenases from the other mammalian collagenases. FEBS Lett 1992; 310: 175-178.
46. Quinn CO, Scott DK. Brinckerhoff CE, Matrisian LM, Jeffrey JJ, Partridge NC. Rat collagenase. Cloning, amino acid sequence comparison, and parathyroid hormone regulation in osteoblastic cells. J Biol Chem 1990; 265: 22342-22347.
47. Lochter A, Srebrow A, Sympson CJ, Terracio N, Werb Z, Bissell MJ. Misregulation of stromelysin-1 expression in mouse mammary tumor cells accompanies acquistion of stromelysin-1-dependent invasive properties. J Biol Chem 1997; 272: 5007-5015.
48. McDonnell S, Matrisian LM. Stromelysin in tumor progression and metastasis. Cancer Metastasis Rev 1990; 9: 305-319.
49. Nakano A, Tani E, Miyazaki K, Furuyama J, Matsumoto T. Expressions of matrilysin and stromelysin in human glioma cells. Biochem Biophys Res Comm 1993; 192: 999-1003.
50. Windsor LJ, Grennett H, Birkedal-Hansen B, Bodden MK, Engler JA, Birkedal-Hansen H. Cell type-specific regulation of SL-1 and SL-2 genes. Induction of the SL-2 gene but not the SL-1 gene by human keratinocytes in response to cytokines and phorbolesters. J Biol Chem 1993; 268: 17341-17347.
51. Murphy G, Ward R, Gavrilovic J, Atkinson S. Physiological mechanisms for metalloproteinase activation. Matrix Supp 1992; 1: 224-230.
52. DeCarlo AA, Windsor LJ, Bodden MK, Harber GJ, Birkedal-Hansen B, Birkedal-Hansen H. Activation and novel processing of matrix metalloproteinases by a thiolproteinase from the oral anaerobe Porphyromonas gingivalis. J Dent Res 1997; 76: 1260-1270.
53. Birkedal-Hansen H, Wells BR, Lin HL, Caufield PW, Taylor RE. Activation of keratinocyte-mediated collagen (Type-I) breakdown by suspected human periodontopathogen. Evidence of a novel mechanism of connective tissue breakdown. J Periodont Res 1984; 19: 645-650.
54. DeCarlo AA, Harber GJ. Hemagglutinin activity and heterogeneity of related Porphyromonas gingivalis proteinases. Oral Microbiol Immunol 1997; 12: 47-56.
55. Lin H-Y, Wells BR, Taylor RE, Birkedal-Hansen H. Degradation of type I collagen by rat mucosal keratinocytes. J Biol Chem 1987; 262: 6823-6831.
56. Birkedal-Hansen H, Cobb CM, Taylor RE, Fulmer HM. Synthesis and release of procollagenase by cultured fibroblasts. J Biol Chem 1976; 251: 3162-3168.
57. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 680-685.
58. Lyons JG, Birkedal-Hansen B, Moore WGI, O'Grady RL, Birkedal-Hansen H. Characteristics of a 95-kDa matrix metalloproteinase produced by mammary carcinoma cells. Biochemistry 1991; 30: 1449-1456.
59. Birkedal-Hansen H. Catabolism and turnover of collagens: collagenases. Methods Enzymol 1987; 144: 140-171.
60. Syed SA, Loesch WJ. Bacteriology of human experimental gingivitis: effect of plaque age. Infect Immun 1978; 21: 821-829.
61. Birkedal-Hansen H, Taylor RE, Zambon JJ, Barwa PK, Neiders ME. Characterization of collagenolytic activity from strains of Bacteroides gingivalis. J Periodont Res 1988; 23: 258-264.
62. Lee C, Levin A, Branton D. Copper staining: a five-minute protein stain for sodium dodecyl sulfate-polyacrylamide gels. Anal Biochem 1987; 166: 308-312.
63. 2-terminal end of the activated enzyme. Biochemistry 1988; 27: 6751-6758.
64. 3H] borohydride. Anal Biochem 1981; 115: 18 -26.
65. Pavloff N, Pemberton PA, Potempa J, et al Molecular cloning and characterization of Porphyromonas gingivalis lysine-specific gingipain. A new member of an emerging family of pathogenic bacterial cysteine proteinases. J Biol Chem 1997; 272: 1595-1600.
66. Knäuper V, Will H, López-Otin C. et al. Cellular mechanisms for human procollagenase-3 (MMP-13) activation. J Biol Chem 1996; 271: 17124-17131.
67. Pei D, Weiss SJ. Transmembrane-deletion mutants of the membrane-type matrix metalloproteinase-1 process progelatinase A and express intrinsic matrix-degrading activity. J Biol Chem 1996; 271: 9135-9140.
68. Okada A, Tomasetto C, Lutz Y, Bellocg J-P, Rio M-C, Basset P, Expression of matrix metalloproteinases during rat skin wound healing: evidence that membrane type I matrix metalloproteinase is a stromal activator of progelatinase A. J Cell Biol 1997; 137: 67-77.
69. Butler GS, Will H, Atkinson SJ, Murphy G. Membrane-type-2 matrix metalloproteinase can initiate the processing of progelatinase A and is regulated by the tissue inhibitors of metalloproteinases. Eur J Biochem 1997; 244: 653-657.
70. Mazzicri R, Masiero L, Zanetta L, et al. Control of type IV collagenase activity by components of the urokinaseplasmin system: a regulatory mechanism with cell-bound reactants. EMBO J 1997; 16: 2319-2332.
71. Baramova EN, Bajou K, Remacle A, et al. Involvement of PA/plasmin system in the processing of pro-MMP-9 and in the second step of pro-MMP-2 activation. FEBS Lett 1997; 405: 157-162.
72. Keski-Oja J, Lohi J, Tuuttila A, Tryggvason K, Vartio T. Proteolytic processing of the 72,000-Da type IV collagenase by urokinase plasminogen activator. Exp Cell Res 1992; 202: 471-476.
73. Potempa J, Pike R, Travis J. Titration and mapping of the active site of cysteine proteinases from Porphyromonas gingivalis (Gingipains) using peptidyl chlormethanes. Biol Chem 1997; 378: 223-230.
74. Ohuchi E, Imai K, Fujii Y, Sato H, Motoharu S, Okada Y. Membrane type I matrix metalloproteinase digests interstitial collagens and other extracellular matrix macromolecules. J Biol Chem 1997; 272: 2446-2451.
75. Knäuper V, Cowell S, Smith B, et al. The role of the C-terminal domain of human collagenase-3 (MMP-13) in the activation of procollagenase-3, substrate specificity, and tissue inhibitor of metalloproteinase interaction. J Biol Chem 1997; 272: 7608-7616.
76. Werb Z, Aggeler J. Proteases induce secretion of collagenase and plasminogen activator by fibroblasts. Proc Natl Acad Sci USA 1978; 75: 1839-1843.
77. Werb Z, Hembry RM, Murphy G, Aggeler J. Commitment to expression of the metalloendopeptidases, collagenase and stromelysin: relationship of inducing events to changes in cytoskeletal architecture. J Cell Biol 1986; 102: 697-702.
78. Phillips JR, Nadim HS, Layman DL. Alterations in cell morphology and cytoskeletal proteinase in gingival fibroblasts exposed to Bacteroides gingivalis extract. J Periodont Res 1990; 25: 339-346.
79. Petersen MJ, Woodley DT, Stricklin GP, O'Keefe EJ. Production of procollagenase by cultured human keratinocytes. J Biol Chem 1987; 262: 835-840.
80. Partridge CA, Phillips PG, Niedbala MJ, Jeffrey JJ. Localization and activation of type IV collagenase/gelatinase at endothelial focal contacts. Am J Physiol 1997; 272: L813-L822.
81. Brooks PC, Strombland S, Sanders LC, et al. Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin αvβ3. Cell 1996; 85: 683-693.
82. Wang AZ, Wang JC, Fisher GW, Diamond HS. Interleukin-Iß-stimulated invasion of articular cartilage by rheumatoid synovial fibroblasts is inhibited by antibodies to specific integrin receptors and by collagenase inhibitors. Arth Rheum 1997; 40: 1298-1307.
83. Bewsey KE, Wen C, Purple C, Homandberg GA. Fibronectin fragments induce the expression of stromelysin-1 mRNA and protein in bovine chondrocytes. Biochem Biophys Acta 1996; 1317: 55-64.
84. Uitto V-J, Larjava H, Hcino J, Sorsa T. A protease of Bacteroides gingivalis degrades cell surface and matrix glycoproteins of cultured gingival fibroblasts and induces secretion of collagenase and plasminogen activator. Infect Immun 1989; 57: 213-218.
85. Larjava H, Uitto V-J, Haapasalo M, Heino J, Vuento M. Fibronectin fragmentation induced by dental plaque and Bacteroides gingivalis. Scand J Dent Res 1987; 95: 308-314.
86. Sorsa T, Uitto V-J, Suomalainen K, Rurto H, Lindy S. A trypsin-like protease from Bacteroides gingivalis: partial purification and characterization. J Periodont Res 1987; 22: 375-380.